Review
doi: 10.1038/nrd1494.
Nanosuspensions in drug delivery
Affiliations
- PMID: 15340388
- DOI: 10.1038/nrd1494
Item in Clipboard
Review
Nanosuspensions in drug delivery
Nat Rev Drug Discov.
2004 Sep.
Abstract
A surprisingly large proportion of new drug candidates emerging from drug discovery programmes are water insoluble, and therefore poorly bioavailable, leading to abandoned development efforts. These so-called 'brickdust' candidates can now be rescued by formulating them into crystalline nanosuspensions. In the process of overcoming issues involving solubility, additional pharmacokinetic benefits of the drugs so formulated have come to be appreciated. As such, insolubility issues of the past have provoked a paradigm change, which now offers novel solutions for innovative drugs of the future.
Similar articles
-
Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.J Control Release. 2008 Jul 2;129(1):1-10. doi: 10.1016/j.jconrel.2008.03.021. Epub 2008 Apr 1. J Control Release. 2008. PMID: 18499294 Review.
-
Nanosuspensions: a promising drug delivery strategy.J Pharm Pharmacol. 2004 Jul;56(7):827-40. doi: 10.1211/0022357023691. J Pharm Pharmacol. 2004. PMID: 15233860 Review.
-
Strategies at the interface of drug discovery and development: early optimization of the solid state phase and preclinical toxicology formulation for potential drug candidates.J Med Chem. 2010 Aug 26;53(16):5897-905. doi: 10.1021/jm1002638. J Med Chem. 2010. PMID: 20527889 No abstract available.
-
Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs.Int J Pharm. 2007 Aug 1;340(1-2):126-33. doi: 10.1016/j.ijpharm.2007.03.011. Epub 2007 Mar 12. Int J Pharm. 2007. PMID: 17600645
-
The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs.Int J Pharm. 2004 Oct 13;284(1-2):109-22. doi: 10.1016/j.ijpharm.2004.07.019. Int J Pharm. 2004. PMID: 15454302 Review.
Cited by
-
Aminoclay-lipid hybrid composite as a novel drug carrier of fenofibrate for the enhancement of drug release and oral absorption.Int J Nanomedicine. 2016 Mar 15;11:1067-76. doi: 10.2147/IJN.S101116. eCollection 2016. Int J Nanomedicine. 2016. PMID: 27042061 Free PMC article.
-
X-ray-computed tomography contrast agents.Chem Rev. 2013 Mar 13;113(3):1641-66. doi: 10.1021/cr200358s. Epub 2012 Dec 5. Chem Rev. 2013. PMID: 23210836 Free PMC article. Review. No abstract available.
-
Fabrication of isradipine nanosuspension by anti-solvent microprecipitation-high-pressure homogenization method for enhancing dissolution rate and oral bioavailability.Drug Deliv Transl Res. 2013 Oct;3(5):384-91. doi: 10.1007/s13346-012-0081-3. Drug Deliv Transl Res. 2013. PMID: 25788346
-
Development of a new method to assess nanocrystal dissolution based on light scattering.Pharm Res. 2012 Oct;29(10):2887-901. doi: 10.1007/s11095-012-0795-4. Epub 2012 Jun 12. Pharm Res. 2012. PMID: 22688901
-
The effect of surface treatment on the brain delivery of curcumin nanosuspension: in vitro and in vivo studies.Int J Nanomedicine. 2019 Jul 19;14:5477-5490. doi: 10.2147/IJN.S199624. eCollection 2019. Int J Nanomedicine. 2019. PMID: 31409999 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
